You are here
Clinical Trials: Cord Blood
Discuss
Condition: Psoriasis
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
Conditions: Safety Issues; Effect of Drugs; Neonatal Death
Interventions: Drug: 0.9% Sodium-chloride; Other: Autologous Umbilical Cord Blood Stem Cells Therapy
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Interventions: Drug: 0.9% Sodium-chloride; Other: Autologous Umbilical Cord Blood Stem Cells Therapy
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Conditions: AML; NHL; Hodgkin Disease; All
Intervention: Drug: Hyperbaric oxygen
Sponsor: University of Rochester
Not yet recruiting
Intervention: Drug: Hyperbaric oxygen
Sponsor: University of Rochester
Not yet recruiting
Condition: Acute Ischemic Stroke
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Conditions: Hematopoietic Stem Cell Transplantation; Haplo-identical Donor; Cord Blood; Hematologic Diseases
Interventions: Procedure: haplo-SCT; Procedure: haplo-cord SCT
Sponsor: The First Affiliated Hospital of Soochow University
Recruiting
Interventions: Procedure: haplo-SCT; Procedure: haplo-cord SCT
Sponsor: The First Affiliated Hospital of Soochow University
Recruiting
Conditions: Safety Issues; Effect of Drugs
Interventions: Other: autologous umbilical cord blood stem cells; Drug: 0.9% Sodium-chloride
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Interventions: Other: autologous umbilical cord blood stem cells; Drug: 0.9% Sodium-chloride
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Condition: Androgenic Alopecia
Interventions: Other: conditioned media of umbilical cord blood-derived stem cells; Other: Placebo
Sponsor: Medipost Co Ltd.
Not yet recruiting
Interventions: Other: conditioned media of umbilical cord blood-derived stem cells; Other: Placebo
Sponsor: Medipost Co Ltd.
Not yet recruiting
Conditions: Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Biphenotypic/Undifferentiated Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Relapsed Large Cell Lymphoma; Mantle Cell Lymphoma; Hodgkin Lymphoma; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Lymphoplasmacytic Lymphoma
Interventions: Drug: Fludarabine (FLU); Drug: Cyclophosphamide (CY); Drug: Total Body Irradiation (TBI); Drug: Tacrolimus (Tac); Drug: Mycophenolate Mofetil (MMF); Drug: Granulocyte Colony-Stimulating Factor (G-CSF); Drug: Busulfan (BU); Drug: Melphalan; Drug: MGTA 456 Infusion
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting
Interventions: Drug: Fludarabine (FLU); Drug: Cyclophosphamide (CY); Drug: Total Body Irradiation (TBI); Drug: Tacrolimus (Tac); Drug: Mycophenolate Mofetil (MMF); Drug: Granulocyte Colony-Stimulating Factor (G-CSF); Drug: Busulfan (BU); Drug: Melphalan; Drug: MGTA 456 Infusion
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting
Condition: Ulcerative Colitis (UC)
Interventions: Biological: Adipose-cord mesenchymal stromal cells (A-MSCs); Other: Conventional drugs
Sponsor: Liaocheng People's Hospital
Recruiting
Interventions: Biological: Adipose-cord mesenchymal stromal cells (A-MSCs); Other: Conventional drugs
Sponsor: Liaocheng People's Hospital
Recruiting
Conditions: CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation; Drug: Carmustine; Drug: Cytarabine; Drug: Etoposide; Biological: Filgrastim; Drug: Melphalan; Biological: Rituximab; Biological: Umbilical Cord Blood-derived Natural Killer Cells
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation; Drug: Carmustine; Drug: Cytarabine; Drug: Etoposide; Biological: Filgrastim; Drug: Melphalan; Biological: Rituximab; Biological: Umbilical Cord Blood-derived Natural Killer Cells
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
